Latest Publications

Share:

Limits of Inherent Anticipation in Product-By-Process Claims

RESTEM, LLC v. JADI CELL, LLC - Before Moore, Schall, and Taranto. Appeal from the Patent Trial and Appeal Board. Inherency in product-by-process claims requires the prior art process to inevitably produce the claimed...more

Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences

In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson, the plaintiffs successfully overcame a motion to dismiss. At the heart of the case is J&J’s legal strategy against biosimilar competitors, including...more

Ambiguous Phrase in a Patent Assignment Precludes Summary Judgment Regarding Standing

Before Dyk, Mayer, and Taranto. Appeal from the Central District of California. Summary: Applying California law, the phrase “entirely on my own time” in an employment agreement was found ambiguous and therefore precluded...more

Navigating the Regulatory Landscape: FDA Approval and Patent Protection for Software as a Medical Device

Software is increasingly used as a medical device, transforming the healthcare industry with the goal of improving patient outcomes. However, developing software as a medical device involves navigating complex and evolving...more

Stipulation of Non-Infringement Found Insufficient for Appeal

Before Lourie, Dyk, and Stoll. Appeal from the United States District Court for the District of Delaware. ALTERWAN, INC. V. AMAZON.COM, INC., AMAZON WEB SERVICES, INC. Summary: The Federal Circuit declined to reach the...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide